207 related articles for article (PubMed ID: 27554682)
1. Semaphorins 4A and 4D in chronic inflammatory diseases.
Chapoval SP; Vadasz Z; Chapoval AI; Toubi E
Inflamm Res; 2017 Feb; 66(2):111-117. PubMed ID: 27554682
[TBL] [Abstract][Full Text] [Related]
2. Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor.
Smith EP; Shanks K; Lipsky MM; DeTolla LJ; Keegan AD; Chapoval SP
BMC Immunol; 2011 May; 12():30. PubMed ID: 21595947
[TBL] [Abstract][Full Text] [Related]
3. Biology and function of neuroimmune semaphorins 4A and 4D.
Nkyimbeng-Takwi E; Chapoval SP
Immunol Res; 2011 May; 50(1):10-21. PubMed ID: 21203905
[TBL] [Abstract][Full Text] [Related]
4. The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases.
Wu M; Li J; Gao Q; Ye F
Expert Opin Ther Targets; 2016 Jul; 20(7):885-901. PubMed ID: 26732941
[TBL] [Abstract][Full Text] [Related]
5. Immune semaphorins: a new area of semaphorin research.
Kumanogoh A; Kikutani H
J Cell Sci; 2003 Sep; 116(Pt 17):3463-70. PubMed ID: 12893810
[TBL] [Abstract][Full Text] [Related]
6. Semaphorins: a new class of immunoregulatory molecules.
Takegahara N; Kumanogoh A; Kikutani H
Philos Trans R Soc Lond B Biol Sci; 2005 Sep; 360(1461):1673-80. PubMed ID: 16147531
[TBL] [Abstract][Full Text] [Related]
7. The role of semaphorins in immune responses and autoimmune rheumatic diseases.
Nishide M; Kumanogoh A
Nat Rev Rheumatol; 2018 Jan; 14(1):19-31. PubMed ID: 29213125
[TBL] [Abstract][Full Text] [Related]
8. Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.
Yoshida Y; Ogata A; Kang S; Ebina K; Shi K; Nojima S; Kimura T; Ito D; Morimoto K; Nishide M; Hosokawa T; Hirano T; Shima Y; Narazaki M; Tsuboi H; Saeki Y; Tomita T; Tanaka T; Kumanogoh A
Arthritis Rheumatol; 2015 Jun; 67(6):1481-90. PubMed ID: 25707877
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin 4A, 4C, and 4D: Function comparison in the autoimmunity, allergy, and cancer.
Rajabinejad M; Asadi G; Ranjbar S; Afshar Hezarkhani L; Salari F; Gorgin Karaji A; Rezaiemanesh A
Gene; 2020 Jul; 746():144637. PubMed ID: 32244055
[TBL] [Abstract][Full Text] [Related]
10. Neuroimmune semaphorin 4A as a drug and drug target for asthma.
Mogie G; Shanks K; Nkyimbeng-Takwi EH; Smith E; Davila E; Lipsky MM; DeTolla LJ; Keegan AD; Chapoval SP
Int Immunopharmacol; 2013 Nov; 17(3):568-75. PubMed ID: 23994348
[TBL] [Abstract][Full Text] [Related]
11. Soluble SEMA4D/CD100: A novel immunoregulator in infectious and inflammatory diseases.
Maleki KT; Cornillet M; Björkström NK
Clin Immunol; 2016 Feb; 163():52-9. PubMed ID: 26732857
[TBL] [Abstract][Full Text] [Related]
12. The role of immune semaphorins in multiple sclerosis.
Okuno T; Nakatsuji Y; Kumanogoh A
FEBS Lett; 2011 Dec; 585(23):3829-35. PubMed ID: 21420960
[TBL] [Abstract][Full Text] [Related]
13. The emerging roles of semaphorin4D/CD100 in immunological diseases.
Wang L; Li X; Song Y; Song D; Huang D
Biochem Soc Trans; 2020 Dec; 48(6):2875-2890. PubMed ID: 33258873
[TBL] [Abstract][Full Text] [Related]
14. The role of immune semaphorins in the pathogenesis of multiple sclerosis: Potential therapeutic targets.
Lotfi R; Nasiri Kalmarzi R; Rajabinejad M; Hasani S; Zamani F
Int Immunopharmacol; 2021 Jun; 95():107556. PubMed ID: 33756227
[TBL] [Abstract][Full Text] [Related]
15. Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.
Miyagaki T; Fujimoto M; Sato S
Int Immunol; 2015 Oct; 27(10):495-504. PubMed ID: 25957264
[TBL] [Abstract][Full Text] [Related]
16. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
Evans EE; Jonason AS; Bussler H; Torno S; Veeraraghavan J; Reilly C; Doherty MA; Seils J; Winter LA; Mallow C; Kirk R; Howell A; Giralico S; Scrivens M; Klimatcheva K; Fisher TL; Bowers WJ; Paris M; Smith ES; Zauderer M
Cancer Immunol Res; 2015 Jun; 3(6):689-701. PubMed ID: 25614511
[TBL] [Abstract][Full Text] [Related]
17. Neuronal semaphorins regulate a primary immune response.
Moretti S; Procopio A; Boemi M; Catalano A
Curr Neurovasc Res; 2006 Nov; 3(4):295-305. PubMed ID: 17109625
[TBL] [Abstract][Full Text] [Related]
18. Generation and preclinical characterization of an antibody specific for SEMA4D.
Fisher TL; Reilly CA; Winter LA; Pandina T; Jonason A; Scrivens M; Balch L; Bussler H; Torno S; Seils J; Mueller L; Huang H; Klimatcheva E; Howell A; Kirk R; Evans E; Paris M; Leonard JE; Smith ES; Zauderer M
MAbs; 2016; 8(1):150-62. PubMed ID: 26431358
[TBL] [Abstract][Full Text] [Related]
19. Possible pathogenic engagement of soluble Semaphorin 4D produced by γδT cells in medication-related osteonecrosis of the jaw (MRONJ).
Movila A; Mawardi H; Nishimura K; Kiyama T; Egashira K; Kim JY; Villa A; Sasaki H; Woo SB; Kawai T
Biochem Biophys Res Commun; 2016 Nov; 480(1):42-47. PubMed ID: 27720716
[TBL] [Abstract][Full Text] [Related]
20. Neuroimmune Semaphorin 4A in Cancer Angiogenesis and Inflammation: A Promoter or a Suppressor?
Iyer AS; Chapoval SP
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30598022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
